{"contacts": [{"terms": [{"accession": "MS:1000586", "name": "contact name", "value": "Swamy Kumar Polumuri"}, {"accession": "MS:1000589", "name": "contact email", "value": "swamykumar.polumuri@fda.hhs.gov"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "FDA"}, {"accession": "MS:1002037", "name": "dataset submitter"}]}, {"terms": [{"accession": "MS:1002332", "name": "lab head"}, {"accession": "MS:1000586", "name": "contact name", "value": "Michael A. Norcross, MD Montserrat Puig, PhD"}, {"accession": "MS:1000589", "name": "contact email", "value": "Montserrat.Puig@fda.hhs.gov"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "Laboratory of Immunology, Division of Biotechnology Review and Research III, Office of Biotechnology Products,Center for Drugs Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA"}]}], "datasetFiles": [{"accession": "MS:1002851", "name": "Other type file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/02/PXD024212/checksum.txt"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/02/PXD024212/B721.5701 FLX 2a.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/02/PXD024212/B721.5701 FLX1a.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/02/PXD024212/B721.5701 Medium 2a.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/02/PXD024212/B721.5701 Medium1a.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/02/PXD024212/B721.5701 FLX 1b.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/02/PXD024212/B721.5701 FLX 2b.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/02/PXD024212/B721.5701 Medium 1b.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/02/PXD024212/B721.5701 Medium 2b.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/02/PXD024212/Flu67_3 11315-qb-qb _KAAkLKEKY.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/02/PXD024212/Flu71_1r-qb 10201_RTTkVGIVGKY.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/02/PXD024212/Flu77_1-qb 15494_TAAQITQRkW.raw"}, {"accession": "MS:1002851", "name": "Other type file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/02/PXD024212/Peptides_Proteins_MP and Proteins_MP.xlsx"}, {"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/02/PXD024212/peptide.csv"}], "description": "Flucloxacillin (FLX), a \uf062-lactam antibiotic for narrow-spectrum gram-positive bacterial infections, has been associated with severe immune-mediated drug-induced liver injury caused by an influx of T-lymphocytes targeting liver cells potentially recognizing drug-haptenated peptides in the context of HLA-B*57:01.", "fullDatasetLinks": [{"accession": "MS:1002852", "name": "Dataset FTP location", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/02/PXD024212"}, {"accession": "MS:1001930", "name": "PRIDE project URI", "value": "http://www.ebi.ac.uk/pride/archive/projects/PXD024212"}], "identifiers": [{"accession": "MS:1001919", "name": "ProteomeXchange accession number", "value": "PXD024212"}], "instruments": [{"accession": "MS:1001911", "name": "Q Exactive"}], "keywords": [{"accession": "MS:1001925", "name": "submitter keyword", "value": "Flucloxacillin, HLA-B*57:01, drug hypersensitivity, hapten, immunogenicity, transgenic mice"}, {"accession": "MS:1002340", "name": "ProteomeXchange project tag", "value": "Human Immuno-Peptidome Project (HUPO-HIPP) (B/D-HPP)"}, {"accession": "MS:1002340", "name": "ProteomeXchange project tag", "value": "Biology/Disease-Driven Human Proteome Project (B/D-HPP)"}, {"accession": "MS:1002340", "name": "ProteomeXchange project tag", "value": "Human Proteome Project"}], "modifications": [{"accession": "MOD:00765", "name": "cysteinylation (disulfide with free L-cysteine)"}, {"accession": "MOD:00394", "name": "acetylated residue"}, {"accession": "MOD:00425", "name": "monohydroxylated residue"}, {"accession": "MOD:00219", "name": "L-citrulline"}], "publications": [{"terms": [{"accession": "MS:1002858", "name": "Dataset with its publication pending"}]}], "species": [{"terms": [{"accession": "MS:1001469", "name": "taxonomy: scientific name", "value": "Homo sapiens (Human)"}, {"accession": "MS:1001467", "name": "taxonomy: NCBI TaxID", "value": "9606"}]}], "title": "Alterations in the HLA-B*57:01 immunopeptidome by flucloxacillin and immunogenicity of drug-haptenated peptides"}